163 related articles for article (PubMed ID: 9854584)
1. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
3. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal carcinoid tumors: factors that predict outcome.
Van Gompel JJ; Sippel RS; Warner TF; Chen H
World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
[TBL] [Abstract][Full Text] [Related]
5. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.
Jaffee IM; Rahmani M; Singhal MG; Younes M
Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
[TBL] [Abstract][Full Text] [Related]
6. Developments in diagnosis and treatment of metastatic midgut carcinoid tumors. A review.
Taal BG; Smits M
Minerva Gastroenterol Dietol; 2005 Dec; 51(4):335-44. PubMed ID: 16282961
[TBL] [Abstract][Full Text] [Related]
7. Foregut carcinoids: a clinical and biochemical analysis.
Kirshbom PM; Kherani AR; Onaitis MW; Hata A; Kehoe TE; Feldman C; Feldman JM; Tyler DS
Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194
[TBL] [Abstract][Full Text] [Related]
8. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
Perez EA; Koniaris LG; Snell SE; Gutierrez JC; Sumner WE; Lee DJ; Hodgson NC; Livingstone AS; Franceschi D
World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tumors of the gastrointestinal tract.
Chejfec G; Falkmer S; Askensten U; Grimelius L; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866
[TBL] [Abstract][Full Text] [Related]
11. [Current concepts on diagnosis and treatment of carcinoid].
Krysiak R; Okopień B; Herman ZS
Przegl Lek; 2007; 64(2):103-10. PubMed ID: 17892042
[TBL] [Abstract][Full Text] [Related]
12. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
13. Large bowel carcinoid tumors.
Northrop JA; Lee JH
Curr Opin Gastroenterol; 2007 Jan; 23(1):74-8. PubMed ID: 17133089
[TBL] [Abstract][Full Text] [Related]
14. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
15. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
Mårtensson H; Nobin A; Sundler F
Acta Chir Scand; 1983; 149(6):607-16. PubMed ID: 6650073
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of carcinoid tumours.
Wheeler MH; Maddox P; Maddineni S; Jordan S; Amer K; Butchart E
Przegl Lek; 2000; 57 Suppl 5():95-7. PubMed ID: 11202311
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor imaging: predictive and prognostic considerations.
Anthony LB; Martin W; Delbeke D; Sandler M
Digestion; 1996; 57 Suppl 1():50-3. PubMed ID: 8813470
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and carcinoid tumors.
Ahlman H
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
[TBL] [Abstract][Full Text] [Related]
20. Carcinoids associated with multiple endocrine neoplasia syndromes.
Duh QY; Hybarger CP; Geist R; Gamsu G; Goodman PC; Gooding GA; Clark OH
Am J Surg; 1987 Jul; 154(1):142-8. PubMed ID: 2886072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
